Stock listing
Transcenta Holding Limited
Selected listing: 6628 · HKEX · HKD · HK
Transcenta Holding Limited (HKEX:6628), Health Technology. Latest release Sep 30, 2026: CANCELLATION AND GRANT OF AWARD PURSUANT TO THE SHARE INCENTIVE SCHEME.
- Ticker
- HKEX:6628
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- HKEX
- Currency
- HKD
About Transcenta Holding Limited
The company is focused on developing innovative biopharmaceuticals to address unmet medical needs. Transcenta aims to leverage its proprietary technology platforms to advance its product pipeline and enhance patient outcomes.
Latest news from Transcenta Holding Limited
CANCELLATION AND GRANT OF AWARD PURSUANT TO THE SHARE INCENTIVE SCHEME
September 30, 2026
Transcenta Therapeutics Presents New Data for its Novel LIV1-Targeting ADC TST013 Demonstrating Potent Anti-Tumor Activity in PDX Models of Prostate Cancer and ER Positive /HER2 Negative Breast Cancer
April 23, 2026
Transcenta Therapeutics Appoints Dr. Christopher Hwang as Head of Global Partnerships for HiCB Platform
March 30, 2026
Transcenta Therapeutics to Present at the 36th Annual Oppenheimer Healthcare Life Sciences Conference
February 24, 2026
Transcenta Therapeutics Announces Strategic Collaboration and Non-exclusive Licensing Agreement to Advance Integrated Continuous Biomanufacturing and Expand Global Access to Affordable Biologics
December 27, 2025
Research Transcenta Holding Limited
Transcenta Holding Limited company profile
View the public company page for Transcenta Holding Limited on 6ix.
Transcenta Holding Limited news
Read company news and market updates connected to Transcenta Holding Limited.
Transcenta Holding Limited investor events
Find investor webinars, events, and replay context for Transcenta Holding Limited.